1Isner JM, Vale PR, Symes JF, et al. Assessment of risks associated with cardiovascular gene therapy in human subjects. Circ Res, 2001, 89: 389-400.
2Coffey MJ, Coles B, O′Donnell VB. Interactions of nitric oxide-derived reactive nitrogen species with peroxidases and lipoxygenases. Free Radic Res, 2001, 35: 447-464.
3Li H, Forstermann U. Nitric oxide in the pathogenesis of vascular disease. J Pathol,2000, 190: 244-254.
5Qian H, Neplioueva V, Shetty GA, et al. Nitric oxide synthase gene therapy rapidly reduces adhesion molecule expression and inflammatory cell infiltration in carotid arteries of cholesterol-fed rabbits. Circulation,1999, 99: 2979-2982.
6Zanetti M, Sato J, Jost CJ, et al. Gene transfer of manganese superoxide dismutase reverses vascular dysfunction in the absence but not in the presence of atherosclerotic plaque. Hum Gene Ther,2001, 12: 1407-1416.
7Bolli R. Cardioprotective function of inducible nitric oxide synthase and role of nitric oxide in myocardial ischemia and preconditioning: an overview of a decade of research. J Mol Cell Cardiol, 2001, 33: 1897-1918.
8Varenne O, Sinnaeve P, Gillijns H, et al. Percutaneous gene therapy using recombinant adenoviruses encoding human herpes simplex virus thymidine kinase, human PAI-1, and human NOS3 in balloon-injured porcine coronary arteries. Hum Gene Ther, 2000, 11: 1329-1339.
9Teupe C, Richter S, Fisslthaler B, et al. Vascular gene transfer of phosphomimetic endothelial nitric oxide synthase (S1 177D) using ultrasound-enhanced destruction of plasmid-loaded microbubbles improves vasoreactivity. Circulation, 2002, 105: 1104-1109.
10Tanner FC, Meier P, Greutert H, et al. Nitric oxide modulates expression of cell cycle regulatory proteins: a cytostatic strategy for inhibition of human vascular smooth muscle cell proliferation. Circulation, 2000, 101: 1982-1989.
同被引文献7
1Kader KN, Akella R, Ziats NP, et al. ENOS-overexpressing endothelial cells inhibit platelet aggregation and smooth muscle cell proliferation in vitro. Tissue Eng, 2000, 6930:241-251.
2Sirois MG, Simons M, Edelman ER, et al. Antisense oligonucleotide inhibition of PDGF-β receptor subunit expression directs suppression of intimal thicking. Circulation, 1997,95:669-676.
3Bellamkonda RV, Kader K, Akella R, et al. Gene therapy approaches in the cardiovascular system. Cell Eng, 1997, 2:66.
4Greisler HP, McGurrin JF, Klosak JJ, et al. The validity of canine platelet aggregometry in predicting vascular graft patency. J Cardiovasc Surg, 1990, 31:712.
5Binion DG, Fu S, Ramanujam KS, et al. iNOS expression in human intestinal microvascular endothelial cells inhibits leukocyte adhesion. Am J Physiol, 1998, 275: 592.
6Tanner FC, Meier P, Greutert H, et al. Nitric oxide modulates expression of cell cycle regulatory proteins: a cytostatic strategy for inhibition of human vascular smooth muscle cell proliferation. Circulation, 2000, 101: 1982-1989.
